Iovance wins with Amtagvi and the ADC train chugs on
- Author
- BioSpace
- Published
- Wed 21 Feb 2024
- Episode Link
- https://podcasters.spotify.com/pod/show/biospace/episodes/Iovance-wins-with-Amtagvi-and-the-ADC-train-chugs-on-e2g2cu9
This week Lori, Greg and Tyler discuss the Accelerated Approval of Amtagvi, the first one-time cell therapy for solid tumors and the first TIL therapy; the FTC and HHS probe into generic drug shortages and some recent ADC-focused raises from ProfoundBio and Firefly Bio.
